Literature DB >> 11071876

Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils.

H Yamane1, Y Sugimoto, S Tanaka, A Ichikawa.   

Abstract

The expression and function of prostaglandin (PG) E(2) receptors were examined in mouse neutrophils exudated into the peritoneal cavity by casein treatment. Expressions of the EP2 and EP4 receptors were detected in neutrophils by Northern blot, but those of EP1 and EP3 receptors were not detected by RT-PCR. EP2-selective agonist, ONO-AE1-259, and EP4-selective agonist, ONO-AE1-329, stimulated cAMP formation in the cells. PGE(2) affected the TNF-alpha and IL-6 production in lipopolysaccharide (LPS)-treated neutrophils; it suppressed the TNF-alpha production and enhanced the IL-6 production. The PGE(2) effects were mimicked by dibutyryl cAMP. This is the first study of the enhancement of IL-6 production by cAMP-elevating reagents in neutrophils. Using neutrophils from EP2- and EP4-deficient mice in combination with EP2- and EP4-selective agonists, it was found that the augmentation of IL-6 was mediated mainly by the EP2 receptor and the suppression of TNF-alpha by the EP4 receptor and partially by the EP2 receptor. These findings indicate that casein-induced peritoneal neutrophils express Gs-coupled PGE(2) receptors, EP2 and EP4, which might differentially regulate the LPS-induced production of TNF-alpha and IL-6. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071876     DOI: 10.1006/bbrc.2000.3779

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

Review 1.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

2.  Docosahexaenoic acid differentially affects TNFα and IL-6 expression in LPS-stimulated RAW 264.7 murine macrophages.

Authors:  Kaori L Honda; Stefania Lamon-Fava; Nirupa R Matthan; Dayong Wu; Alice H Lichtenstein
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2015-04-11       Impact factor: 4.006

3.  Time-dependent mediators of HPA axis activation following live Escherichia coli.

Authors:  Z R Zimomra; V M Porterfield; R M Camp; J D Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-14       Impact factor: 3.619

Review 4.  Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

Authors:  Jianxiong Jiang; Ray Dingledine
Journal:  Trends Pharmacol Sci       Date:  2013-06-21       Impact factor: 14.819

5.  Dectin-1 plays an important role in host defense against systemic Candida glabrata infection.

Authors:  Si Min Chen; Hui Shen; Teng Zhang; Xin Huang; Xiao Qi Liu; Shi Yu Guo; Jing Jun Zhao; Chun Fang Wang; Lan Yan; Guo Tong Xu; Yuan Ying Jiang; Mao Mao An
Journal:  Virulence       Date:  2017-07-31       Impact factor: 5.882

Review 6.  Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases.

Authors:  Eva H C Tang; Peter Libby; Paul M Vanhoutte; Aimin Xu
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

7.  Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.

Authors:  Hideo Inoue; Makiko Takamori; Yoshihito Shimoyama; Hideaki Ishibashi; Seizo Yamamoto; Yasuko Koshihara
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Role of PDE4 in superoxide anion generation through p44/42MAPK regulation: a cAMP and a PKA-independent mechanism.

Authors:  Claire Jacob; Corinne Szilagyi; Janet M Allen; Claude Bertrand; Vincent Lagente
Journal:  Br J Pharmacol       Date:  2004-08-16       Impact factor: 8.739

9.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

10.  Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice.

Authors:  Jonathan M Gitlin; Charles D Loftin
Journal:  Cardiovasc Res       Date:  2008-10-22       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.